Post Profile






NCCN Congress to Explore Complex Issues in Treating Hematologic Malignancies

The NCCN 11th Annual Congress: Hematologic Malignancies(tm) returns to New York City September 30 - October 1, 2016; registration is still open at NCCN.org/HEM
read more

share

Related Posts


2017 Hemmings Motor News Concours d’Elegance announces featured marques

Vehicles / Cars : Hemmings.com

During this past weekend’s 10th annual Hemmings Motor News Concours d’Elegance presented by Gullwing Motor Cars, the event staff announced the featured marques for its 11th annual three-day extravaganza, to be held on September 22-2...

NCCN Receives $2 Million in Research Funding from Boehringer Ingelheim to Study Volasertib in Hematologic Malignancies

Health : Newswise Medical News

The NCCN Oncology Research Program (ORP) received a $2-million grant from Boehringer Ingelheim Pharmaceuticals, Inc. to facilitate studies of volasertib in hematologic malignancies.

NCCN Awards Grants to Three Researchers to Investigate Volasertib in Hematologic Malignancies

Health : Newswise Medical News

The NCCN Oncology Research Program has awarded three research grants to investigate the safety and effectiveness of volasertib in hematologic malignancies.

NCCN Awarded $2 Million in Research Funding from Infinity Pharmaceuticals to Study Duvelisib in Hematologic Malignancies

Health : Newswise Medical News

The NCCN Oncology Research Program (ORP) was awarded a $2-million grant from Infinity Pharmaceuticals, Inc. to facilitate studies of duvelisib in the treatment of hematologic malignancies.

NCCN to Host 9th Annual Congress: Hematologic Malignancies(tm) in New York, NY

Health : Newswise Medical News

The National Comprehensive Cancer Network(r) (NCCN(r)) will host its 9th Annual Congress: Hematologic Malignancies(tm) in New York, NY, September 19 - 20, 2014.

Comments


Copyright © 2016 Regator, LLC